CMS announces new repayment terms for Accelerated and Advance Payment programs

Oct 09, 2020 - 01:45 PM
CMS logo

The Centers for Medicare & Medicaid Services yesterday announced new repayment terms for payments received under its Accelerated and Advance Payment programs, including a longer time period before repayment, lower recoupment rates during repayment, lower interest on remaining unpaid balance, and additional repayment flexibilities.

The announcement implements provisions of the Continuing Appropriations Act, 2021 and Other Extensions Act, which was enacted on Oct. 1, 2020.

The repayment terms are amended for all providers and suppliers who requested and received AAPs during the COVID-19 public health emergency. In addition to describing the new terms, CMS announced that the agency no longer will accept applications for AAPs as they relate to COVID-19. CMS also clarified that Provider Relief Funds can be used toward repayment of these Medicare loans.

Related News Articles

Headline
District court rules in favor of Tennessee’s 340B contract pharmacy law
The U.S. District Court for the Middle District of Tennessee June 30 denied a motion for a preliminary injunction by AbbVie in its lawsuit against the state’s…
Headline
AHA files amicus brief in second lawsuit challenging Tennessee’s 340B contract pharmacy law 
The AHA June 27 filed an amicus brief in the U.S. District Court for the Middle District of Tennessee that defends the state’s 340B contract pharmacy law…
Headline
OSHA proposes removing remaining requirements of its COVID-19 emergency temporary standard
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational…
Chairperson's File
Chair File: Leadership Dialogue — Legal Advocacy to Protect Hospitals With AHA General Counsel Chad Golder
Public
Advocacy is a core part of the work of the AHA, protecting and sustaining what hospitals and health systems need to truly care for our communities. We often…
Headline
Judge rules against J&J, for HHS and 340B hospitals in rebate model case
A U.S. District Court for the District of Columbia judge June 27 ruled against Johnson & Johnson and sided with the Department of Health and Human Services…
Headline
AHA report: Hospitals are complying with 340B rules, but drug companies are not 
The AHA June 16 released a report showing hospitals that participated in the 340B Drug Pricing Program are not only subject to disproportionately greater…